COMMUNIQUÉS West-GlobeNewswire

Dentsply Sirona Declares Quarterly Cash Dividend
25/04/2018
YORK, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0. [...]
Paratek Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018
25/04/2018
BOSTON, April 25, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Progenics Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
25/04/2018
Pivotal Phase 2 AZEDRA Data Selected for Oral Presentation NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging [...]
R1 RCM to Release First Quarter 2018 Results on May 9
25/04/2018
CHICAGO, April 25, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]
Dentsply Sirona to Host First Quarter 2018 Conference Call on May 7th
25/04/2018
YORK, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live [...]
Osiris Announces New Peer-Reviewed Publication Summarizing Clinical Outcomes of Viable Cryopreserved Placental Membranes for Management of Chronic Diabetic Foot Ulcers in Real World Setting
25/04/2018
COLUMBIA, Md., April 25, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine [...]
BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting
25/04/2018
NEW YORK, April 25, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that the [...]
FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary
25/04/2018
WESTLAKE VILLAGE, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]
Dyadic International to Announce First Quarter 2018 Financial Results and Host Conference Call on Thursday May 10, 2018
25/04/2018
JUPITER, Fla., April 25, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help [...]
Vital Therapies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/04/2018
SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today reported [...]
Burcon Announces Delisting From Nasdaq Capital Market
25/04/2018
VANCOUVER, British Columbia, April 25, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]
Golden Leaf Holdings Appoints Rick Miller to Board of Directors
25/04/2018
TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced [...]
Conatus Pharmaceuticals to Report First Quarter 2018 Financial Results
25/04/2018
SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ) today announced that it will report financial results for the first quarter ended March 31, 2018, after the market close on [...]
Marrone Bio Innovations and Lidorr Chemicals Ltd. Sign Distribution Agreement in Israel
25/04/2018
DAVIS, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII ) (MBI) and Lidorr Chemicals Ltd. (LCL) today announced their partnership to distribute a range of novel biopesticides for [...]
BioTelemetry, Inc. Reports First Quarter 2018 Financial Results
25/04/2018
Company Exceeds Revenue and Adjusted EBITDA Expectations MALVERN, Pa., April 25, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile and wireless medical technology company focused on the [...]
LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
25/04/2018
BURLINGTON, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ), a provider of vascular devices, implants and services, today reported Q1 2018 results, provided guidance, and announced a $0 [...]
PRA Health Sciences Announces Retirement of Chief Financial Officer and Promotion of Michael Bonello to CFO
25/04/2018
RALEIGH, N.C., April 25, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) today announced that Linda Baddour, Executive Vice President and Chief Financial Officer will retire from her position as CFO, [...]
Ossur Hf : Updated financial calendar for the financial year 2018
25/04/2018
Announcement no. 32/2018 25 April 2018 Updated financial calendar for the financial year 2018 Compared with the previously announced financial calendar, company announcement no. 87/2017, 13 December 2017, Össur has [...]
Calithera Biosciences Announces CB-839 Abstracts Accepted for Presentation at ASCO 2018
25/04/2018
SOUTH SAN FRANCISCO, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, today [...]

Pages